within Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XX01_SodiumPhosphate32p;
model SodiumPhosphate32p 
   extends Pharmacolibrary.Drugs.ATC.V.V10XX01;

  annotation(Documentation(
    info ="<html><body><p>Sodium phosphate (32P) is a radiopharmaceutical used in the treatment of certain blood disorders and cancers, such as polycythemia vera and chronic leukemia. It is a beta-emitting radioactive isotope, formerly used for palliative and therapeutic purposes. Its clinical use has declined significantly due to newer therapies and its serious side effect profile.</p><h4>Pharmacokinetics</h4><p>No direct human pharmacokinetic data or parameter values published in peer-reviewed literature for sodium phosphate (32P) could be found. Below are estimated pharmacokinetic parameters based on typical behavior of inorganic phosphate and radiopharmaceutical distribution in adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end SodiumPhosphate32p;
